ACADIA Pharmaceuticals's total assets for Q3 2025 were $1.33B, an increase of 8.59% from the previous quarter. ACAD total liabilities were $413.50M for the fiscal quarter, a 2.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.